Perbedaan Kalbe Farma Tbk dan Solusi Bangun Indonesia Tbk.: Kalbe Farma Tbk diperdagangkan di Rp735 (kapitalisasi pasar 35,34 T, volume 24 jam 108,3 jt), sedangkan Solusi Bangun Indonesia Tbk. diperdagangkan di Rp775 (kapitalisasi pasar 6,99 T). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 5,1× kapitalisasi pasar Solusi Bangun Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | SMCB | |
|---|---|---|
Kapitalisasi Pasar | 35,34 T | 6,99 T |
Volume | 108,3 jt | — |
Lot | 1,08 jt | — |
Perputaran | 80,02 M | — |
Harga Rata-rata | 738,89 | — |
Nilai Transaksi | 80,02 M | — |
Harga Ekuilibrium Indikatif | 735 | — |
Volume Ekuilibrium Indikatif | 59,74 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.
Selengkapnya di halaman SMCB →